Volume 7 Supplement 6
Cell cycle and apoptosis: a map for the GS-NS0 cell line at the genetic level and the link to environmental stress
© Usaku et al.; licensee BioMed Central Ltd. 2013
Published: 4 December 2013
Large scale mammalian cell culture systems, especially fed-batch systems, are currently utilised to manufacture monoclonal antibodies (MAbs) in order to meet the continuously growing global demand . Nutrient deprivation and toxic metabolite accumulation commonly encountered in such systems influence the cell cycle and trigger apoptosis, resulting in shorter culture times and a lower final MAb titre. Control of the cell cycle has been previously studied in order to achieve higher titre through apoptosis inhibition by bcl-2 overexpression and cell cycle arrest in G1/G0 by p21 transfection. However, the above mentioned strategies have not always been successful; no improvement in titre was often observed though bcl-2 over-expression helped prolong the culture viability whereby the majority of cells were arrested at G1/G0 to avoid apoptosis [2–4]. Thus, a systematic insight of the dynamic relation between metabolic stress, cell cycle and apoptosis is still required. To this end, we aim to establish a novel map of the dynamic interplay between cell cycle and apoptosis at the genetic level, and provide a link with the culture conditions at the metabolic level.
Materials and methods
Batch culture of GS-NS0 producing a cB72.3 MAb was performed. Cell density and viability was quantified using the dye exclusion method. Extracellular glucose, glutamate, lactate and ammonium were quantified using Bioprofile 400 (Nova Biomedical, Waltham, USA). The extracellular antibody was measured using ELISA. DNA staining and Annexin V/PI assay was used to quantify the fraction of cells in each cell cycle phase as well as the degree of apoptosis. The measurement of both apoptosis and cell cycle related gene expression was conducted using real-time PCR.
Results and discussion
Our results showed a clear link between the environmental factors and gene expression. The batch cultures started with a high fraction of cells in the G1/G0 phase, which rapidly left this state in order to join the proliferating population. Soon after, glutamate deprivation occurred at around 50 h of culture, whereby atf5 upregulation peaked (50% higher) suggesting that glutamate deprivation is among the first factors that introduce metabolic stress, in agreement with previous results . The upregulation of atf5 triggered the upregulation of bcl-2 (which followed at around 90 h). After the batch cultures reached their maximum cell density (which occurred roughly the same time as the glutamate exhaustion), the onset of an increasing early apoptotic cell population was observed - around 10%. Together with the high cell density, casp8 was upregulated (100% increase). Consequently, the expression of casp3 followed a similar trend with a lag of few hours as its protein, caspase-3, is one of downstream targets of caspase-8 and a final executor of the apoptosis pathways . In addition, trp53bp2 showed a similar trend to casp3. These results suggest that apoptosis could initially occur via the death receptor pathway as marked by the casp8 upregulation, which might be induced by the glutamate exhaustion and/or the cell density peak. However, given that the trp53bp2 upregulation happened later than that of casp8 suggests that apoptosis in the later stages of culture might also occur through the mitochondrial pathway and it could also be triggered by other lethal signals (e.g. high level of lactate accumulation). As soon as the onset of apoptosis occurred, the upregulation of p21 was also observed (300% increase) and this happened simultaneously with the bcl-2 upregulation. Since it was reported that Bcl-2 protein helps facilitate cell cycle arrest at G1/G0 phase and an increase in G1/G0 cell fraction was observed later in the death phase of culture, this could suggest that the bcl-2 upregulation may underlie the p21 upregulation and the cell cycle arrest at G1/G0 phase and this could be a mechanism to avoid apoptosis .
These findings set a map of the cell cycle and apoptotic timing and magnitudes of the events from the genetic level and their links to the environmental conditions, which can be used to gain insight of the GS-NS0 cultures. By looking at the map, we can systematically analyse cellular responses to the environmental conditions which may have detrimental effect on the culture and utilise the result of the analysis to tackle the culture issues way before the final executors, but at the genetic level. Ultimately, the goal is to utilize mathematical models that will help to establish new strategies in order to achieve a longer cultivation period, high viability and increased MAb titre.
We would like to thank Lonza Biologics (Slough, UK) for kindly providing the cell line and members of Biological Systems Engineering Laboratory (BSEL) for help with the analytical techniques.
- Elvin JG, Couston RG, van der Walle CF: Therapeutic antibodies: Market considerations, disease targets and bioprocessing. International Journal of Pharmaceutics. 2013, 440: 83-98. 10.1016/j.ijpharm.2011.12.039.View ArticlePubMedGoogle Scholar
- Simpson NH, Singh RP, Emery AN, Al-Rubeai M: Bcl-2 over-expression reduces growth rate and prolongs G1 phase in continuous chemostat cultures of hybridoma cells. Biotechnology and Bioengineering. 1999, 64: 174-186. 10.1002/(SICI)1097-0290(19990720)64:2<174::AID-BIT6>3.0.CO;2-D.View ArticlePubMedGoogle Scholar
- Tey BT, Singh RP, Piredda L, Piacentini M, Al-Rubeai M: Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures. Journal of Biotechnology. 2000, 79: 147-159. 10.1016/S0168-1656(00)00223-6.View ArticlePubMedGoogle Scholar
- Watanabe S, Shuttleworth J, Al-Rubeai M: Regulation of cell cycle and productivity in NS0 cells by the over-expression of p21CIP1. Biotechnology and Bioengineering. 2002, 77: 1-7. 10.1002/bit.10112.View ArticlePubMedGoogle Scholar
- Browne SM, Al-Rubeai M: Analysis of an artificially selected GS-NS0 variant with increased resistance to apoptosis. Biotechnology and Bioengineering. 2011, 108: 880-892. 10.1002/bit.22994.View ArticlePubMedGoogle Scholar
- Hengartner MO: The biochemistry of apoptosis. Nature. 2000, 407: 770-776. 10.1038/35037710.View ArticlePubMedGoogle Scholar
- Janumyan YM, Sansam CG, Chattopadhyay A, Cheng N, Soucie EL, Penn LZ, Andrews D, Knudson CM, Yang E: Bcl-xL/Bcl-2 coordinately regulates apoptosis, cell cycle arrest and cell cycle entry. EMBO J. 2003, 22: 5459-5470. 10.1093/emboj/cdg533.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.